Ludvig Ekdahl
Overview
Explore the profile of Ludvig Ekdahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Went M, Duran-Lozano L, Halldorsson G, Gunnell A, Ugidos-Damboriena N, Law P, et al.
Nat Commun
. 2024 Aug;
15(1):6644.
PMID: 39103364
Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies indicate a substantial heritable component, but the underlying mechanisms remain unclear. Here, in a genome-wide association study totaling...
2.
Cafaro C, Ali Z, Lamarca A, Di Bello D, Lozano L, Ekdahl L, et al.
Haematologica
. 2024 May;
109(9):3059-3062.
PMID: 38721738
No abstract available.
3.
Ajore R, Mattsson J, Pertesi M, Ekdahl L, Ali Z, Hansson M, et al.
Blood Cancer J
. 2024 Jan;
14(1):21.
PMID: 38272874
No abstract available.
4.
Ekdahl L, Arrizabalaga A, Ali Z, Cafaro C, Lopez de Lapuente Portilla A, Nilsson B
Bioinform Adv
. 2023 Aug;
3(1):vbad103.
PMID: 37600847
Motivation: AliGater is an open-source framework to accelerate the development of bioinformatic pipelines for the analysis of large-scale, high-dimensional flow cytometry data. AliGater provides a Python package for automatic feature...
5.
Lopez de Lapuente Portilla A, Ekdahl L, Cafaro C, Ali Z, Miharada N, Thorleifsson G, et al.
Blood
. 2022 Jan;
139(11):1659-1669.
PMID: 35007327
Stem cell transplantation is a cornerstone in the treatment of blood malignancies. The most common method to harvest stem cells for transplantation is by leukapheresis, requiring mobilization of CD34+ hematopoietic...
6.
Mattsson J, Ekdahl L, Junghus F, Ajore R, Erlandsson E, Niroula A, et al.
Nat Commun
. 2021 Feb;
12(1):1277.
PMID: 33627649
Therapeutic antibodies are transforming the treatment of cancer and autoimmune diseases. Today, a key challenge is finding antibodies against new targets. Phenotypic discovery promises to achieve this by enabling discovery...
7.
Pertesi M, Ekdahl L, Palm A, Johnsson E, Jarvstrat L, Wihlborg A, et al.
Commun Biol
. 2019 Jul;
2:262.
PMID: 31341961
The landscape of somatic acquired deletions in cancer cells is shaped by positive and negative selection. Recurrent deletions typically target tumor suppressor, leading to positive selection. Simultaneously, loss of a...